In a June letter to Armstrong, subsequently made public, the USADA said samples taken from the cyclist in 2009 and 2010 were "fully consistent with blood manipulation including EPO use and/or blood transfusions."
Read Whole Story
Get top stories and blogs posts emailed to you each day.